Detection of Sotatercept (ACE‐011) in human serum by SAR‐PAGE and western single blotting

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Nachweis von Sotatercept (ACE-011) in Humanserum mittels SAR-PAGE und Western Single Blotting
Autor:Reichel, Christian; Farmer, Letizia; Gmeiner, Günter; Walpurgis, Katja; Thevis, Mario
Erschienen in:Drug testing and analysis
Veröffentlicht:10 (2018), 6, S. 927-937, Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Elektronische Ressource (online) Gedruckte Ressource
Sprache:Englisch
ISSN:1942-7603, 1942-7611
DOI:10.1002/dta.2346
Schlagworte:
Online Zugang:
Erfassungsnummer:PU202011010135
Quelle:BISp

Abstract des Autors

A method for the detection of Sotatercept (ACE‐011, ACVR2A‐Fc) in human serum is presented. The method is a modification of a recently published protocol for Luspatercept (ACE‐536, ACVR2B‐Fc), another erythropoiesis stimulating fusion protein. Out of 27 tested antibodies against either the extracellular domain of ACVR2A or the full‐length protein, only 4 antibodies bound strongly enough to Sotatercept for usage with immunoprecipitation followed by SAR‐PAGE and Western single blotting. The adapted protocol allows the detection of 0.1 ng/mL Sotatercept in just 50 μL human serum. None of the 3 commercial ACVR2‐ELISAs was able to detect Sotatercept and the 2 tested surrogate proteins, even in the μg/mL range. As for Luspatercept, only IPG‐IEF/2D‐PAGE generated discrete isoforms. Due to the long serum half‐life, the SAR‐PAGE method will be able to detect Sotatercept for several weeks and will be very useful in doping testing.